Get 10% Free Customization in this Report
Global Pediatric Proton Therapy Market has potential of more than US$ 700 Million by 2021. Rising pediatric cancer incidence and technological improvement to treat faster per patient will boost the pediatric proton therapy market globally.
United States is the Global Leader in Treating Pediatric Patients with Proton Therapy
USA has the highest pediatric proton therapy market share but in future it will lose its market share, due to competition from Germany, France, United Kingdom and Japan. Proton Therapy is becoming a preferential choice of treatment as its ability to treat pediatric cancer in a more efficient way, compared to traditional radiotherapy. Proton Therapy has achieved importance in such a short duration of time period, due to its technological advancement Like Intensity-Modulated Proton Therapy (IMPT) and Pencil Beam Technology.
United States Age Group of (1-4) has the highest Cancer Evidence in Pediatric Proton Therapy Market
The report captures the USA pediatric proton therapy market data on five age groups (<1) Year, (1-4) Year, (5-9) Year, (10-14) Year, (15-18) Year. In these age groups (1-4) Year has highest market.
Ependymoma Cancerous Tumor holds 15 percent market share in USA Pediatric Proton Therapy Market
The report captures 36 Type of Cancer Market & number of pediatric patients in USA. Ependymoma Cancerous Tumor holds the highest market, among all the other 36 pediatric cancer market.
Germany, United Kingdom and France will drive the Europe Pediatric Proton Therapy Market
Germany holds a significant market share in Global Pediatric Proton Therapy Market. United Kingdom is more concerned about proton therapy especially for pediatric treatment. United Kingdom NHS (National Health Service) used to send massive number of pediatric patients for the proton therapy treatment abroad. Switzerland and France are also developing new proton therapy center. France used to have maximum pediatric proton therapy market share in 2010.
Japan, China & South Korea helping the Proton Therapy Market in Asia to Grow
In Asia, Japan has already established their benchmark for the treatment of pediatric patient with proton therapy. China is more focused toward developing 8 proton therapy centers (Under-construction + Planning Phase) to serve their massive population.
Global Pediatric Proton Therapy Market & Forecast (10 Countries Market Data), Patients Treated is the 20th report published by Renub Research on Proton Therapy Market. This 330 page report with 287 figures and 7 Tables provides 10 Countries: Pediatric Proton Therapy Market, Proton Therapy Patient Numbers, Cancer Type Markets in USA, Technology being used at these Proton Therapy Centers and Reimbursement Policies. The report also studies the Proton Therapy Sales & Forecast of four companies - IBA, Varian Medical Systems, Mitsubishi and Hitachi.
Key Questions Answered in the Report?
• What is the Number of pediatric patients treated by Proton Beam Therapy worldwide?
• What are the reimbursement policies for Proton Therapy across the world?
• What is the Pediatric Proton Therapy Market in United States and Forecast?
• What is the Number of Pediatric Proton Therapy Patients by age group in United States and Forecast
• What is the Number of Pediatric Proton Therapy Patients by tumor type in United States and Forecast
• What is the Pediatric Proton Therapy Market size in Asia (Japan, China and South Korea) and its growth potential in future?
• What is the Number of Pediatric Proton Therapy patients treated in Asia (Japan, China and South Korea)?
• What is the Pediatric Proton Therapy Market in Europe (Germany, France, Sweden, Switzerland, Czech and United Kingdom) and Forecast?
• What is the Number of Pediatric Proton Therapy Patients in Europe (Germany, France, Sweden, Switzerland, Czech and United Kingdom) and Forecast?
• What Type of Technology is being used at Proton Therapy Centers?
Key Companies Proton Therapy Sales Analysis (2010 – 2021)
2. Varian Medical Systems
Countries Pediatric Proton Therapy Market & Number of Patients studied in the Report
1. United States
2. United Kingdom
7. Czech Republic
Sr. Marketing Manager
Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.
Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today’s ultra-competitive markets.